Credit Suisse Ag Novartis Ag Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $903,804 - $1.11 Million	11,963 Added 32332.43%	12,000 $1.09 Million
Q3 2022 Nov 10, 2022	SELL	$74.61 - $87.26 $105,722 - $123,647	-1,417 Reduced 97.46%	37 $3,000
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $149,767 - $174,375	-1,860 Reduced 56.13%	1,454 $123,000
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $212,051 - $239,871	-2,647 Reduced 44.41%	3,314 $291,000
Q4 2021 Feb 14, 2022	SELL	$79.7 - $88.13 $567,782 - $627,838	-7,124 Reduced 54.44%	5,961 $521,000
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $2.95 Million - $3.43 Million	-36,027 Reduced 73.36%	13,085 $1.07 Million
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $4.19 Million - $4.62 Million	49,112 New	49,112 $4.51 Million
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $4.35 Million - $5.26 Million	-55,713 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $4.38 Million - $4.85 Million	53,288 Added 2197.44%	55,713 $4.85 Million
Q2 2020 Aug 12, 2020	SELL	$80.93 - $91.1 $7.86 Million - $8.85 Million	-97,116 Reduced 97.56%	2,425 $212,000
Q1 2020 May 13, 2020	BUY	$70.67 - $99.01 $4.93 Million - $6.91 Million	69,770 Added 234.36%	99,541 $8.21 Million
Q4 2019 Feb 12, 2020	SELL	$84.35 - $95.37 $210,959 - $238,520	-2,501 Reduced 7.75%	29,771 $2.82 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $609,814 - $671,979	-7,129 Reduced 18.09%	32,272 $2.8 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $1.71 Million - $2.11 Million	22,697 Added 135.88%	39,401 $3.6 Million
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $718,929 - $822,301	-9,545 Reduced 36.36%	16,704 $1.61 Million
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $1.31 Million - $1.45 Million	-17,736 Reduced 40.32%	26,249 $2.25 Million
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $575,684 - $665,898	-8,600 Reduced 16.35%	43,985 $3.79 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $2.74 Million - $3.1 Million	42,196 Added 406.16%	52,585 $3.97 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $334,282 - $399,628	-4,749 Reduced 31.37%	10,389 $840,000
Q4 2017 Mar 14, 2018	BUY	$72.33 - $77.64 $111,388 - $119,565	1,540 Added 11.33%	15,138 $1.27 Million
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $3.07 Million - $3.29 Million	-42,386 Reduced 75.71%	13,598 $1.14 Million
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $2.96 Million - $3.08 Million	39,858 Added 247.17%	55,984 $4.81 Million
Q2 2017 Aug 14, 2017	BUY	N/A	16,126	16,126 $1.35 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account